Luís Teixeira

8.5k total citations · 1 hit paper
93 papers, 3.3k citations indexed

About

Luís Teixeira is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luís Teixeira has authored 93 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 25 papers in Cancer Research and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luís Teixeira's work include Breast Cancer Treatment Studies (16 papers), Cancer Treatment and Pharmacology (11 papers) and Medical Imaging Techniques and Applications (10 papers). Luís Teixeira is often cited by papers focused on Breast Cancer Treatment Studies (16 papers), Cancer Treatment and Pharmacology (11 papers) and Medical Imaging Techniques and Applications (10 papers). Luís Teixeira collaborates with scholars based in France, United States and Spain. Luís Teixeira's co-authors include Loı̈c Guillevin, Josep Tabernero, Catherine Dodé, Daniel D. Von Hoff, Brian Lu, Salvatore Siena, Jean‐Luc Van Laethem, A. Bérezné, Christophe Tournigand and Giampaolo Tortora and has published in prestigious journals such as Journal of Clinical Investigation, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Luís Teixeira

87 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

2015 504 citations Josep Tabernero, Luís Teixeira et al. profile →

Peers

Countries citing papers authored by Luís Teixeira

Since Specialization

Citations

This map shows the geographic impact of Luís Teixeira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luís Teixeira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luís Teixeira more than expected).

Fields of papers citing papers by Luís Teixeira

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luís Teixeira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luís Teixeira. The network helps show where Luís Teixeira may publish in the future.

Co-authorship network of co-authors of Luís Teixeira

This figure shows the co-authorship network connecting the top 25 collaborators of Luís Teixeira. A scholar is included among the top collaborators of Luís Teixeira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luís Teixeira. Luís Teixeira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DPYD genotype should be extended to rare variants: report on two cases of phenotype / genotype discrepancy 2025 ·Cancer Chemotherapy and Pharmacology ·Paul Vilquin, Yves Médard, Fabienne Thomas, Lauriane Goldwirt, Luís Teixeira, Samia Mourah, Évelyne Jacqz-Aigrain	2
2	Clinical utility of ctDNA as a tool to detect triple-negative breast cancer relapses: The CUPCAKE trial. 2024 ·Journal of Clinical Oncology ·François‐Clément Bidard, Frédérique Berger, Mónica Arnedos, Marie‐Ange Mouret‐Reynier, Olivier Trédan, Renaud Sabatier, William Jacot, (unknown), Thibault De La Motte Rouge, Joseph Gligorov, Luís Teixeira, Frédéric Fiteni, Julien Grenier, Florence Dalenc, Irène Buvat, (unknown), Nicolas Kiavué	1
3	Diagnostic et prise en charge de la pneumopathie interstitielle diffuse induite par les anticorps conjugués dans le cancer du sein : avis d’expert 2023 ·Bulletin du Cancer ·Luís Teixeira, Véronique Dièras, Bruno Crestani, Mathieu Léderlin, Cristian Villanueva, Boris Duchemann, Jean‐Yves Pierga, Jacques Cadranel	2
4	Impact of the COVID‐19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study 2023 ·Cancer Medicine ·(unknown), (unknown), Guillaume Lamé, Johanna Wassermann, Romain Bey, Catherine Uzan, Gilles Châtellier, Yazid Belkacémi, Xavier Tannier, S. Guillerm, Rémi Flicoteaux, Joseph Gligorov, Ariel Cohen, (unknown), Luís Teixeira, Christel Daniel, Barbara Hersant, Christophe Tournigand, Emmanuelle Kempf	4
5	Overall Survival With Circulating Tumor Cell Count–Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial 2023 ·Journal of Clinical Oncology ·François‐Clément Bidard, Nicolas Kiavué, William Jacot, Thomas Bachelot, Sylvain Dureau, Hugues Bourgeois, Anthony Gonçalvès, Étienne Brain, Sylvain Ladoire, Florence Dalenc, Joseph Gligorov, Luís Teixeira, (unknown), Jean-Marc Ferrero, Delphine Loirat, Luc Cabel, Amir Kadi, Véronique Dièras, Catherine Alix‐Panabières, Jean‐Yves Pierga	28
6	Histological Risk Factors for Local Recurrence of Phyllodes Tumors of the Breast 2022 ·Anticancer Research ·Camille Mimoun, (unknown), (unknown), (unknown), F. Cornélis, Catherine Miquel, (unknown), (unknown), Luís Teixeira, (unknown), Cyrille Huchon	1
7	213MO Primary endpoint analysis of a randomized phase II of darolutamide or capecitabine in patients with triple-negative androgen receptor-positive advanced breast cancer (UCBG3-06 START trial) 2022 ·Annals of Oncology ·Mónica Arnedos, Anthony Gonçalvès, M. Pulido, F. Lerebours, Olivier Trédan, Florence Dalenc, Séverine Guiu, (unknown), Luís Teixeira, (unknown), Benjamin Verret, (unknown), (unknown), (unknown), Sylvain Ladoire, Élisabeth Carola, (unknown), (unknown), Gaëtan MacGrogan, Hervé Bonnefoi	4
8	Ten-Year Outcomes of Hypofractionated Postmastectomy Radiation Therapy of 26 Gy in 6 Fractions 2021 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), L. Quéro, S. Guillerm, (unknown), (unknown), C. Cuvier, Sylvie Giacchetti, (unknown), (unknown), Luís Teixeira, Marc Espié, Christophe Hennequin	3
9	Nonpalpable breast lesions: impact of a second-opinion review at a breast unit on BI-RADS classification 2021 ·European Radiology ·Constance de Margerie‐Mellon, (unknown), Axelle Dupont, C. Cuvier, Sylvie Giacchetti, Luís Teixeira, Marc Espié, C. de Bazelaire	4
10	Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer 2020 ·Cancer Research ·Piotr Przanowski, Song Lou, (unknown), Tanmoy Mondal, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Marty W. Mayo, Luís Teixeira, Jacqueline Lehmann‐Che, (unknown), Sanchita Bhatnagar	23
11	18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis 2017 ·Breast Cancer Research ·David Groheux, Antoine Martineau, Luís Teixeira, Marc Espié, Patricia de Crémoux, Philippe Bertheau, Pascal Merlet, Charles Lemarignier	63
12	Méthotrexate intrathécal dans les méningites carcinomateuses du cancer du sein – Expérience avec le protocole utilisé à l’hôpital Saint-Louis 2016 ·Bulletin du Cancer ·(unknown), Sabrina Corrêa da Costa, Christine Le Maignan, (unknown), Jérôme Cochereau, Marc Espié, Sylvie Giacchetti, Luís Teixeira	5
13	Decreased Numbers of Blood Dendritic Cells and Defective Function of Regulatory T Cells in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 2011 ·PLoS ONE ·Marie Rimbert, M. Hamidou, Cécile Braudeau, Xavier Puéchal, Luís Teixeira, Hélène Caillon, A. Néel, Marie Audrain, Loı̈c Guillevin, Régis Josien	63
14	Squamous-cell carcinoma of the anal canal: Room for improvement with targeted therapy 2011 ·Clinics and Research in Hepatology and Gastroenterology ·(unknown), Luís Teixeira, Paulo M. Hoff, Aimery de Gramont, Christophe Tournigand	2
15	Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls 2011 ·Lara D. Veeken ·L. Guillevin, A. Bérezné, Raphaèle Séror, Luís Teixeira, Jacques Pourrat, Alfred Mahr, É. Hachulla, C. Agard, J. Cabané, Philippe Vanhille, Jean‐Robert Harlé, (unknown), L. Mouthon	105
16	Efficacy of FOLFOX4 as adjuvant therapy in stage II colon cancer (CC): A new analysis of the MOSAIC trial according to risk factors. 2010 ·Journal of Clinical Oncology ·Luís Teixeira, Tamas Hickish, Christophe Tournigand, (unknown), Andrea Bonetti, Francisca Rivera, C. Boni, Josep Tabernero, Thierry André, Aimery de Gramont	5
17	Pollution atmosphérique et cancer bronchique : données épidémiologiques 2009 ·Revue des Maladies Respiratoires ·Jean Trédaniel, (unknown), Luís Teixeira, Francesco Savinelli, (unknown), Dominique Gossot, Christophe Hennequin	7
18	High frequency of venous thromboembolic events in Churg–Strauss syndrome, Wegener’s granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients 2008 ·Annals of the Rheumatic Diseases ·Yves Allenbach, Raphaèle Séror, Christian Pagnoux, Luís Teixeira, Philippe Guilpain, Loı̈c Guillevin	123
19	FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity 2007 ·Nature Genetics ·Manuela Fanciulli, Penny J. Norsworthy, Enrico Petretto, Rong Dong, Lorraine Harper, Lavanya Kamesh, J. M. Heward, Stephen Gough, Adam J. de Smith, Alexandra I. F. Blakemore, Philippe Froguel, Catherine Owen, Simon H. S. Pearce, Luís Teixeira, Loı̈c Guillevin, Deborah S. Cunninghame Graham, Charles D. Pusey, H. Terence Cook, Timothy J. Vyse, Timothy J. Aitman	352
20	Medicamentos e Alimentação na Prevenção do Câncer de Mama 2005 ·(unknown), (unknown), Luís Teixeira, (unknown), (unknown), (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact